4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-25-057683
Chief Executive Officer acquired 55,117 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brumm Joshua T · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-15 | Grant or award : show line 1 in the form | +45,117 | 313,517 | D |
| 2025-12-15 | Grant or award : show line 2 in the form | +10,000 | 323,517 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-15 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +180,467 | 180,467 | D |
Loading xslF345X05/wk-form4_1766007988.xml…